Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -6.35% to $21.54. Supernus Pharmaceuticals, Inc. (SUPN) revealed that positive topline results from its Phase IIb dose-ranging clinical trial of SPN-812 in children for the treatment of attention deficit hyperactivity disorder (ADHD). The trial was successful in meeting the primary endpoint, demonstrating that SPN-812 at daily doses of 400 mg, 300 mg and 200 mg achieved a statistically important improvement in the symptoms of ADHD from baseline to end of study as measured by the ADHD Rating Scale-IV.
All SPN-812 doses tested in the trial were well tolerated. Based on these positive results in children with ADHD and the positive Phase IIa results in adults with ADHD, Supernus plans to have an end-of-Phase II meeting with the U.S. Fda following which it will initiate Phase III clinical testing. The share price of SUPN attracts active investors, as stock price of week volatility recorded 6.84%. The stock is going forward to its 52-week low with 126.50% and lagging behind from its 52-week high price with -19.75%.
Mattel, Inc. (NASDAQ:MAT) [Trend Analysis] climbed reacts as active mover, shares an raise 0.54% to traded at $29.60 and the percentage gap among open changing to regular change was 0.03%. Strengthening its presence in key geographies all through Asia, Mattel, Inc. (MAT)reported that it has finalized strategic relationships with Choirock Contents Factory, Co., Ltd. and Sonokong Co, Ltd., two of Korea’s most successful and established toy industry leaders.
Under the terms of an contract with Choirock, Mattel will serve as master toy licensee for the hugely popular Turning Mecard franchise, presently the number one toy franchise in South Korea by sales1. Under the terms of the accord, Mattel will manufacture, distribute and market a wide variety of toys and products inspired by the franchise, comprising vehicles, action figures, games and other items. Choirock will continue to distribute and manage theTurning Mecard franchise in Korea, while Mattel will hold the right to introduce the franchise in markets all through the world.
Separately, Mattel and Sonokong have entered into a strategic contract in which Sonokong will serve as Mattel’s primary distribution partner in South Korea, with accountability for sales and product distribution. The contract applies to Mattel’s entire product portfolio, not comprising games. Mattel has also entered into a definitive contract to takeover a 12% equity stake in Sonokong, a publicly-traded firm listed on the Korea Exchange (KRX).
The transaction is predictable to be completed later this month. The firm’s current ratio calculated as 1.70 for the most recent quarter. The firm past twelve months price to sales ratio was 1.82 and price to cash ratio remained 32.19. As far as the returns are concern, the return on equity was recorded as 13.80% and return on investment was 9.40% while its return on asset stayed at 5.50%. The firm has total debt to equity ratio measured as 0.93.